Tue, Sep 30, 2014, 9:34 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • larshansson18 larshansson18 Jan 10, 2013 9:45 AM Flag

    I'll try again: There is a new presentation from Onemedplace

    My post that I wrote som 40 min ago seems to be gone, so:

    Watch the new presentation on the new CO:

    Watch out for this one concerning the potential concerning Amket, after 9 min 40 sec:

    "Immune och Epicept is commited to continue partnering discussions and initiate the phase III trial in 2013."

    Also note there is a preclinical out licencing under way 2013.

    Interesting comparisson to competitors for the new drugs from Immune.

    "Låt Stå!"

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • There are also two interviews on the same site, Onemedplace ("database"). The one from July 27 is interesting if you want to know more about the way of action and the commersial way forward for the Immune pipeline.

      Our new CEO also lines out the present values for similar CO.

 
IMNP
3.36+0.07(+2.13%)Sep 30 3:31 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Cyber-Ark Software Ltd.
NasdaqGSTue, Sep 30, 2014 4:00 PM EDT
eBay Inc.
NasdaqGSTue, Sep 30, 2014 4:15 PM EDT
BioCryst Pharmaceuticals, Inc.
NasdaqGSTue, Sep 30, 2014 4:15 PM EDT